Hypoxie und Angiogenese in rheumatischen Erkrankungen = Hypoxia and angiogenesis in rheumatic diseasesDISTLER, O.Zeitschrift für Rheumatologie (Print). 2003, Vol 62, Num 2, pp II43-II45, issn 0340-1855, SUP2Article

Connective tissue diseasesDISTLER, O; MÜLLER-LADNER, U.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, 57 p., SUP3Serial Issue

Angiogenesis and vasculogenesis in systemic sclerosisDISTLER, J. H. W; GAY, S; DISTLER, O et al.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii26-iii27, SUP3Article

Epidemiology of connective tissue disordersGAUBITZ, M.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii3-iii4, SUP3Article

The role of endothelin in connective tissue diseasesSTICHERLING, M.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii8-iii10, SUP3Article

Systemic sclerosis in childhoodFOELDVARI, I.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii28-iii29, SUP3Article

Role of endothelin in chronic renal failure : developments in renal involvementRICHTER, C. M.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii36-iii38, SUP3Article

Clinical trial design in scleroderma: where are we and where do we go next?CHUNG, L; DENTON, C. P; DISTLER, O et al.Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 2, issn 0392-856X, S97-S102, SUP71Article

Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosisDISTLER, J. H. W; AKHMETSHINA, A; SCHETT, G et al.Rheumatology (Oxford. Print). 2009, Vol 48, Num 2, pp 98-103, issn 1462-0324, 6 p.Article

Connective tissue diseases : evaluation of clinical responseFISCHER-BETZ, R; SCHNEIDER, M.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii5-iii7, SUP3Article

Therapeutic modulation of cutaneous autoimmunity by regulatory T cellsLOSER, K; BEISSERT, S.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii20-iii22, SUP3Article

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cellsDISTLER, J. H. W; ALLANORE, Y; TYNDALL, A et al.Annals of the rheumatic diseases. 2009, Vol 68, Num 2, pp 163-168, issn 0003-4967, 6 p.Article

Synovial fibroblasts : key players in rheumatoid arthritisHUBER, L. C; DISTLER, O; TARNER, I et al.Rheumatology (Oxford. Print). 2006, Vol 45, Num 6, pp 669-675, issn 1462-0324, 7 p.Article

A 30 year history of panniculitisDISTLER, O; PALITZSCH, K.-D; HOHENEUTNER, U et al.Journal of rheumatology. 2000, Vol 27, Num 2, pp 507-509, issn 0315-162XConference Paper

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupAVOUAC, J; FRANSEN, J; ALLANORE, Y et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 3, pp 476-481, issn 0003-4967, 6 p.Article

Is there a role for TNF-α antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueDISTLER, J. H. W; JORDAN, S; CUTOLO, M et al.Clinical and experimental rheumatology (Testo stampato). 2011, Vol 29, Num 2, issn 0392-856X, S40-S45, SUP65Article

Angiogenese : Therapeutische Interventionsmöglihkeiten bei rheumatischen Erkrankungen : Molekulare Mechanismen = Angiogenesis. Possibilities for therapeutic intervention in rheumatic diseasesMAURER, B; DISTLER, J. H. W; MORITZ, F et al.Zeitschrift für Rheumatologie (Print). 2007, Vol 66, Num 4, issn 0340-1855, 304, 306-310 [6 p.]Article

Immunological basis of systemic sclerosisZUBER, J.-P; SPERTINI, F.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii23-iii25, SUP3Article

Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosisSUNDERKÖTTER, C; RIEMEKASTEN, G.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii33-iii35, SUP3Article

The role of DMARDs in systemic sclerosis therapyBLANK, N; MAX, R; LORENZ, H.-M et al.Rheumatology (Oxford. Print). 2006, Vol 45, issn 1462-0324, iii42-iii44, SUP3Article

Kardiovaskuläre Manifestationen bei Rheumatoider Arthritis : Schwerpunktthema : Kardiovaskuläre Morbidität und Komorbidität bei Rheumatoider Arthritis und Kollagenosen = Cardiovascular manifestations in rheumatoid arthritis : Main Topic : Cardiovascular morbidity and comorbidity at rheumatoid arthritis and collagenosisMORITZ, F; WAGNER, U; DISTLER, O et al.Zeitschrift für Rheumatologie (Print). 2005, Vol 64, Num 4, pp 222-228, issn 0340-1855, 7 p.Article

Non organ based laboratory markers in systemic sclerosisMCHUGH, N. J; DISTLER, O; GIACOMELLI, R et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 3, pp S.32-S.38, issn 0392-856X, SUP29Conference Paper

Mixed crystal-induced arthropathy - a rare findingTAMBORRINI, G; DISTLER, O; SCHMET, M et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, p. 801Article

Use of methotrexate in patients with scleroderma and mixed connective tissue diseaseKOWAL-BIELECKA, O; DISTLER, O.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, issn 0392-856X, S160-S163, SUP61Article

Overview of pathogenesis of systemic sclerosisABRAHAM, D. J; KRIEG, T; DISTLER, J et al.Rheumatology (Oxford. Print). 2009, Vol 48, issn 1462-0324, iii3-iii7, SUP3Conference Paper